Dyne Therapeutics, Inc.’s 2026 outlook with key DYNE-101/251 data, FDA submission plans, and extended cash runway. Click for ...

The Minister noted that with the development and transfer of India's first indigenous CRISPR-based gene therapy, the nation is moving closer to fulfilling Prime Minister Narendra Modi's goal of ...

A massive genomic study of over 1 million cases found that shared risk across 14 psychiatric disorders is reduced to 5 ...

CAMBRIDGE, Mass., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), an industry innovator developing ...

Metagenomic sequencing of stool samples from 225 hospital patients and healthy volunteers reveals the impact of different antimicrobial exposures on the gut microbiome.

STK-012 is an α/β biased IL-2 partial agonist designed to stimulate antigen-activated T cells while avoiding IL-2 associated toxicities Positive Phase 1b data recently presented at SITC 2025, with a ...

The Conejo Valley’s life science moment is here — driven by global leaders, emerging innovators, modern infrastructure, and a skilled workforce.

We conclude that brain states are shaped by local circuit mechanisms, large-scale connectivity and neuromodulation. A unified multiscale theory of cortical dynamics is relevant not only for ...

Lyric Bio, Inc., (Lyric) a next-generation biomanufacturing startup developing human-tissue-based production systems for donor-derived therapeutics, has closed an oversubscribed $6.6 million seed ...

Bristol Myers Squibb (NYSE: BMY) today announced the presentation of more than 95 data disclosures, including 27 oral presentations, across company-sponsored studies and external collaborations at the ...

Menstrual blood is emerging as a powerful tool in women’s health, offering promising diagnostic accuracy and regenerative stem cell potential for future medical breakthroughs.

With me today are four members of the Editas executive team, our Chief Medical Officer, Baisong Mei; our Chief Financial ...